[Pharmacological properties and clinical efficacy of garenoxacin mesilate hydrate (Geninax Tablet 200 mg), a quinolone antimicrobial].
Tsuda
Hisatsugu
H
hisatsugu_tsuda@toyama-chemical.co.jp
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D004352:Drug Resistance, Microbial; D024841:Fluoroquinolones / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy / Q000382:microbiology; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013607:Tablets; D013810:Therapeutic Equivalency
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D013607:Tablets; C419689:garenoxacin